Raymond James Trust’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,996
| Closed | -$624K | – | 1158 |
|
|
2020
Q4 | $624K | Buy |
3,996
+96
| +2% | +$12.3K | 0.02% | 469 |
|
|
2020
Q3 | $446K | Buy |
3,900
+445
| +13% | +$48K | 0.02% | 527 |
|
|
2020
Q2 | $388K | Buy |
3,455
+795
| +30% | +$84.4K | 0.02% | 555 |
|
|
2020
Q1 | $239K | Buy |
2,660
+636
| +31% | +$62.4K | 0.01% | 644 |
|
|
2019
Q4 | $219K | Buy |
+2,024
| New | +$216K | 0.01% | 847 |
|
|
2019
Q3 | – | Sell |
-2,611
| Closed | -$342K | – | 979 |
|
|
2019
Q2 | $342K | Buy |
2,611
+204
| +8% | +$26.3K | 0.02% | 566 |
|
|
2019
Q1 | $325K | Sell |
2,407
-247
| -9% | -$30.7K | 0.02% | 576 |
|
|
2018
Q4 | $259K | Sell |
2,654
-29
| -1% | -$3.43K | 0.02% | 610 |
|
|
2018
Q3 | $373K | Buy |
2,683
+271
| +11% | +$34K | 0.02% | 545 |
|
|
2018
Q2 | $299K | Buy |
2,412
+80
| +3% | +$9.35K | 0.02% | 622 |
|
|
2018
Q1 | $260K | Sell |
2,332
-361
| -13% | -$43.1K | 0.02% | 579 |
|
|
2017
Q4 | $322K | Buy |
2,693
+561
| +26% | +$68.3K | 0.02% | 520 |
|
|
2017
Q3 | $299K | Buy |
2,132
+456
| +27% | +$62K | 0.02% | 535 |
|
|
2017
Q2 | $204K | Sell |
1,676
-635
| -27% | -$73.9K | 0.02% | 661 |
|
|
2017
Q1 | $281K | Sell |
2,311
-1,424
| -38% | -$184K | 0.02% | 520 |
|
|
2016
Q4 | $457K | Sell |
3,735
-200
| -5% | -$24.5K | 0.04% | 375 |
|
|
2016
Q3 | $483K | Sell |
3,935
-333
| -8% | -$42.9K | 0.04% | 344 |
|
|
2016
Q2 | $499K | Buy |
4,268
+643
| +18% | +$91.2K | 0.04% | 331 |
|
|
2016
Q1 | $505K | Buy |
3,625
+32
| +0.9% | +$4.7K | 0.05% | 327 |
|
|
2015
Q4 | $686K | Buy |
3,593
+2,109
| +142% | +$368K | 0.06% | 278 |
|
|
2015
Q3 | $232K | Buy |
1,484
+271
| +22% | +$49.4K | 0.03% | 502 |
|
|
2015
Q2 | $219K | Buy |
+1,213
| New | +$209K | 0.02% | 551 |
|
|
2015
Q1 | – | Sell |
-1,103
| Closed | -$204K | – | 669 |
|
|
2014
Q4 | $204K | Sell |
1,103
-285
| -21% | -$52.8K | 0.02% | 566 |
|
|
2014
Q3 | $230K | Buy |
+1,388
| New | +$228K | 0.03% | 512 |
|
|
2014
Q2 | – | Sell |
-1,394
| Closed | -$212K | – | 635 |
|
|
2014
Q1 | $212K | Buy |
+1,394
| New | +$222K | 0.03% | 512 |
|
Other funds holding ALXN
FCM
HI
PCM
DKCM
BBA
